01.17.23 -- AI In Trials: Biopharma Execs Express Concern

Most life sciences execs agree that their companies — even early adopters of AI — still need to make significant changes to leverage AI properly. Here's how to get started (or keep forging ahead).

The European Union Clinical Trial Regulation No. 536/2014 introduced the most significant changes to the processes for clinical trial applications in the past 15 years. Learn how it impacts the trial master file and consider three key functions that an electronic TMF must have.

Explore how eConsent became the solution when a study design proved to be too expensive and difficult to execute using a traditional trial approach.

Download this guide for five key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.

The clinical research industry has been reluctant to adopt eConsent for several reasons, not least of which included having to disrupt already stressed and short-staffed work environments. Read how the industry should continue exploring and implementing digital technologies in earnest.

GSK leveraged an agile approach and modern ways of working to help shorten their EDC build times. Learn how they reduced EDC build and UAT times by 50% and had all new studies built in 18 months.

In today’s tale of excitement and suspense, discover the differences between paper and electronic TMFs as well as the similarities they share.

LifeSphere CTMS is built to enhance clinical development productivity. This video shows how LifeSphere CTMS helps achieve productivity goals.

ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle CTMS by helping providers and sponsors better understand current trends surrounding this technology and be able to anticipate future ones.

Trial Interactive’s Transport Integration provides increased efficiency, security, and compliance to the certified document translation request process.